Key Findings: 

Sidhu and Slater used a 60-day greenhouse mesocosm model to evaluate the dissemination of multiple antimicrobial resistance genes (ARGs) as well as the class 1 integron-integrase marker (intI1), a key mediator of resistance gene capture and horizontal transfer, following soil treatment with biosolids (sewage sludge) or effluent-treated wastewater. Assessments were performed across wastewater residuals, soil, crops (pea, radish, and lettuce), earthworms, and leachate before and after soil treatment.¹

• Matrix-specific dissemination patterns: Biosolids carried the highest absolute loads of antibiotics and ARGs, whereas effluent contained lower concentrations but exhibited greater dispersal potential. Soil served primarily as a “receiver matrix.”
• ARG-specific dissemination patterns: Distinct ARGs behaved differently depending on the wastewater residual matrix.
  • qnrS (quinolone/fluoroquinolone resistance) preferentially leached from effluent-treated systems.
  • sul1 and sul2 (sulfonamide resistance genes) demonstrated greater dissemination from biosolid-amended soils, highlighting gene-specific environmental behavior.
• Earthworms as ARG bioaccumulators: Earthworms accumulated substantially higher ARG burdens than soil, leachate, or plant materials, reaching concentrations of approximately 10⁷–10⁸ gene copies per gram dry weight, suggesting that earthworms may function as ecological reservoirs and vectors for ARG transfer.
• Evidence of environmental mobility: ARGs were detected not only in soil samples but also in leachate and biological compartments, supporting the concept that wastewater facilitates environmental dissemination through interconnected pathways.
• Limited but detectable plant uptake: Plants generally demonstrated low ARG bioaccumulation; however, ARGs were detected within edible pea pods, indicating potential pathways for entry into agricultural food systems.

Bigger Picture:

The study showed that the different resistance genes and the integron marker behaved differently depending on whether the contamination source was treated wastewater effluent or biosolids. This demonstrated that ARG dissemination is gene-specific and matrix-dependent rather than uniform. Broadly speaking, this study highlights that AMR is not solely a clinical issue but also an environmental one. Wastewater residuals can act as ecological reservoirs that promote persistence, amplification, and horizontal spread of ARGs through soil ecosystems and food webs. The findings challenge traditional wastewater risk assessments focused soley on chemicals or pathogens and support the need for environmental ARG surveillance and One Health-based AMR mitigation strategies.

References:

Key Findings: 

This review by Sutanto and Fetarayani summarizes current synthetic approaches for engineering the gut microbiome, focusing on genetic tool development, engineered microbial systems, and translational constraints in commensal-based platforms.¹

• Synthetic biology tools for microbiome engineering: shift from native microbial traits to genetic manipulation of commensal organisms via:
  • Emerging CRISPR–Cas genome editing systems for use in E. coli Nissle and Bacteroides spp.
  • Modular plasmid systems with engineered expression cassettes, biosensors, secretion tags, and CRISPR-compatible scaffolds (including tracrRNA-based designs) to improve editing efficiency and plasmid stability.
• Engineered commensals as living therapeutics: Gut bacteria can be genetically modified to sense disease-related signals and produce therapeutic molecules in response, functioning as programmable and controllable drug delivery systems within the host.
• Synthetic gene elements that enable complex biological responses: Engineered microbes that can detect specific environmental or host-derived cues, process signals, and execute defined biological responses such as metabolite production or gene activation. 
• Microbial consortia engineering: Synthetic microbial communities can be designed with division of labor, metabolic complementarity, and ecological stability in mind to improve functional robustness.
• Ecological modeling for stability and persistence: Successful microbiome engineering requires predictive ecological models to ensure engineered strains remain stable, competitive, and functional within complex gut environments.
• Translational and clinical applications: Potential applications include targeted treatment of metabolic disease, gastrointestinal disorders, immune dysregulation, and systemic inflammatory conditions.
• Key translational barriers: Major challenges include biosafety risks, ecological unpredictability, regulatory uncertainty, and long-term genetic stability of engineered traits in vivo.

Bigger Picture:

The gut microbiome is increasingly viewed as a programmable system in which engineered microbes can be deployed as dynamic therapeutic agents capable of sensing, responding, and adapting to the host environment. However, we are not quite there yet. The transition from concept to clinical reality remains constrained by fundamental challenges in microbial ecology, safety containment, and regulatory frameworks. Ensuring stability of engineered organisms in the highly competitive and variable gut ecosystem is a central unresolved problem. 

References:

1. Sutanto and Fetarayani. 2026. Engineering the Gut Microbiome: Synthetic Biology Approaches for Human Health and Disease. Gut Microbiology.

Key Findings: 

This review examines how AI-integrated biosensors are improving food safety testing in complex food matrices through the combination of advanced biorecognition systems and machine learning algorithms.¹ Major concepts covered include: 

• AI reduces matrix interference: Machine learning models, particularly convolutional neural networks (CNNs), improve signal interpretation by reducing background noise, nonspecific interactions, and matrix-induced variability commonly encountered in food samples.
• Rapid pathogen detection: AI-enhanced biosensor systems demonstrated detection of foodborne pathogens at colony-forming-unit levels within approximately 60 min, substantially faster than conventional culture-based workflows.
• Improved classification accuracy: Automated feature extraction and pattern-recognition algorithms improved classification performance across diverse food matrices, supporting more reliable detection in heterogeneous food systems.
• Integration with CRISPR-based detection: Combining AI with CRISPR–Cas biosensors enabled highly specific nucleic acid detection with improved signal interpretation and potential for rapid, low-infrastructure testing platforms.
• Potential for real-time monitoring: AI-supported biosensors facilitate automated analysis, portable deployment, and near–real-time decision-making, supporting continuous monitoring throughout the food supply chain.
• Key translational challenges remain:
  • Dependence on large, high-quality datasets
  • Inter-laboratory variability and lack of standardization
  • Enzyme instability and biosensor robustness issues
  • Regulatory validation and explainable AI requirements.

Bigger Picture:

This review captures a fundamental shift in food safety diagnostics—from chemistry- and biology-limited detection systems to data-driven, adaptive sensing platforms. Traditional biosensors struggle in real-world conditions because food matrices introduce variability that cannot be easily controlled through assay chemistry alone. AI effectively becomes a computational layer that compensates for biochemical noise, enabling reliable detection in environments where classical methods fail.

References:

1. Fatemi. et al. 2026. AI-Powered Biosensors for Food Safety: Resolving Biomolecular Challenges in Complex Food Matrices. Food and Bioproducts Processing.

Key Findings: 

Akimbekova et al. report on a field-deployable RPA–CRISPR/Cas12a molecular platform for rapid detection of Salmonella enterica.¹ The workflow integrates isothermal recombinase polymerase amplification (RPA) with CRISPR/Cas12a-mediated detection targeting multiple pathogen-specific genes (stn, siiD, sirA, and pagN). Following 20 minutes of RPA amplification at 37°C, products were incubated with a pre-assembled Cas12a/crRNA complex for 10–30 minutes at 37°C. Target sequence recognition activated Cas12a collateral cleavage, resulting in cleavage of a FAM-labeled reporter, with results visualized under UV light with the naked eye.

Performance characteristics

• Analytical sensitivity: Detection limit of 10² copies per reaction within ~10 minutes, demonstrated using the pagN gene target. 
• Specificity:  Inclusivity confirmed across 4 target Salmonella strains. Exclusivity demonstrated against 6 non-target organisms, with no cross-reactivity observed.

Bigger Picture:

This study reflects the accelerating transition toward CRISPR-based molecular diagnostics as next-generation tools for foodborne pathogen detection. The integration of isothermal amplification (RPA) with CRISPR/Cas12a specificity overcomes key limitations of conventional PCR by eliminating thermocycling requirements while maintaining high analytical performance.  

However, key studies are required to address: 

• Broader selectivity analysis
• Sample matrix inhibition in real-world samples 
• Requires redesign for emerging strains or novel variants 

Overall, RPA–CRISPR/Cas12a systems represent a strong intermediate step toward fully integrated, sample-to-answer pathogen detection platforms.

References:

1. Akimbekova et al., 2026. Integrated RPA–CRISPR/Cas12a Technology for Rapid Detection of Salmonella enterica. Diagnostics.